Wangning Gu

530 total citations · 2 hit papers
10 papers, 287 citations indexed

About

Wangning Gu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wangning Gu has authored 10 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wangning Gu's work include Epigenetics and DNA Methylation (4 papers), Immune cells in cancer (3 papers) and Ferroptosis and cancer prognosis (3 papers). Wangning Gu is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Immune cells in cancer (3 papers) and Ferroptosis and cancer prognosis (3 papers). Wangning Gu collaborates with scholars based in China. Wangning Gu's co-authors include Tengfei Xiao, Pan Chen, Hongmin Yang, Ling Tang, Minghua Yang, Bo Xiang, Yifan Liu, Hui Wang, Yuzhen Ouyang and Dan Wang and has published in prestigious journals such as Molecular Cancer, Signal Transduction and Targeted Therapy and Cell Death and Disease.

In The Last Decade

Wangning Gu

10 papers receiving 285 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective

2024 95 citations Yifan Liu, Yuzhen Ouyang et al. Signal Transduction and Targeted Therapy profile →
Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes

2024 52 citations Huai Liu, Ling Tang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wangning Gu China	6	169	83	66	60	50	10	287
Wanqiong Yuan China	8	107 0.6×	72 0.9×	42 0.6×	80 1.3×	50 1.0×	14	224
Liaoran Niu China	11	157 0.9×	98 1.2×	71 1.1×	100 1.7×	42 0.8×	30	325
Cuiping Wang China	12	176 1.0×	79 1.0×	30 0.5×	54 0.9×	68 1.4×	26	312
Zonglong Wu China	12	195 1.2×	70 0.8×	76 1.2×	70 1.2×	51 1.0×	19	331
Ziqin Liu China	9	192 1.1×	89 1.1×	24 0.4×	46 0.8×	37 0.7×	26	275
Zhouting Tuo China	10	133 0.8×	60 0.7×	65 1.0×	61 1.0×	39 0.8×	45	279
Gunjan Sharma India	8	119 0.7×	35 0.4×	39 0.6×	55 0.9×	60 1.2×	23	259
Taylor A. Johnson United States	8	170 1.0×	48 0.6×	30 0.5×	36 0.6×	35 0.7×	19	319
Huihui Yao China	8	130 0.8×	94 1.1×	67 1.0×	97 1.6×	61 1.2×	22	268

Countries citing papers authored by Wangning Gu

Since Specialization

Citations

This map shows the geographic impact of Wangning Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangning Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangning Gu more than expected).

Fields of papers citing papers by Wangning Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangning Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangning Gu. The network helps show where Wangning Gu may publish in the future.

Co-authorship network of co-authors of Wangning Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Wangning Gu. A scholar is included among the top collaborators of Wangning Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangning Gu. Wangning Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Zhang, Haixia, Siyang Liu, Dan Wang, et al.. (2025). Combining decitabine with radiotherapy to enhance nasopharyngeal carcinoma radiosensitivity via the TFAP2C-OTUD1-SLC25A11 axis. Cell Death and Disease. 16(1). 525–525. 2 indexed citations

2.

Fu, Yaw‐Syan, Ling Tang, Bo Song, et al.. (2025). O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma. Neoplasia. 62. 101142–101142. 3 indexed citations

3.

Li, Shizhen, Dan Wang, Siyang Liu, et al.. (2024). Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomarker Research. 12(1). 96–96. 53 indexed citations

4.

Liu, Feng, Ling Tang, Yanzhu Chen, et al.. (2024). Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2. Cell Death and Disease. 15(4). 279–279. 20 indexed citations

5.

Liu, Huai, Yanxian Li, Ling Tang, et al.. (2024). UBR5 metabolically reprograms nasopharyngeal carcinoma cells to promote glycolysis and M2 polarization via SPLUNC1 signaling. npj Precision Oncology. 8(1). 252–252. 3 indexed citations

6.

Liu, Yifan, Yuzhen Ouyang, Wangning Gu, et al.. (2024). Pyroptosis in health and disease: mechanisms, regulation and clinical perspective. Signal Transduction and Targeted Therapy. 9(1). 245–245. 95 indexed citations breakdown →

7.

Liu, Huai, Ling Tang, Yanxian Li, et al.. (2024). Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes. Molecular Cancer. 23(1). 20–20. 52 indexed citations breakdown →

8.

Tang, Ling, Sha Gong, Tengfei Xiao, et al.. (2023). USP7 inhibits the progression of nasopharyngeal carcinoma via promoting SPLUNC1-mediated M1 macrophage polarization through TRIM24. Cell Death and Disease. 14(12). 852–852. 18 indexed citations

9.

Chen, Pan, Dan Wang, Tengfei Xiao, et al.. (2023). ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma. International Immunopharmacology. 122. 110629–110629. 38 indexed citations

10.

Tang, Ling, Ling Peng, Huai Liu, et al.. (2022). SPLUNC1 regulates LPS-induced progression of nasopharyngeal carcinoma and proliferation of myeloid-derived suppressor cells. Medical Oncology. 39(12). 214–214. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact